Check out our most popular compounded medications! Get Started
The Tretinoin 10 mg/ml Gastric Tube Liquid is a specially compounded medication intended for administration through a gastric tube. This formulation is designed to provide accurate dosing and safe delivery of tretinoin to patients who are unable to take medications orally. Tretinoin is a retinoid commonly used in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia characterized by the accumulation of immature granulocytes known as promyelocytes. The liquid form ensures that patients with swallowing difficulties or those in a hospital setting can receive their necessary medication without the need for oral ingestion.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Tretinoin 10 mg/ml Gastric Tube Liquid is a specialized formulation designed for patients who require medication administration via a gastric tube. This method of delivery is particularly beneficial for individuals who are unable to take oral medications, which includes patients with dysphagia (difficulty swallowing), those with neurological disorders affecting the swallow reflex, or patients who are unconscious or on mechanical ventilation in a hospital setting.
Tretinoin, the active ingredient in this formulation, is a derivative of vitamin A and is commonly used in the treatment of acute promyelocytic leukemia (APL). APL is a subtype of acute myeloid leukemia characterized by the accumulation of immature granulocytes called promyelocytes. Tretinoin works by promoting the differentiation and maturation of these cells, thereby reducing the number of immature cells in the blood and bone marrow. This action helps to restore normal hematopoiesis (the formation of blood cellular components) and alleviates the symptoms associated with the disease. It is important to note that the use of tretinoin for APL is highly specific and should be initiated under the guidance of an oncologist or a healthcare professional specialized in the treatment of blood cancers.
For prescribers considering this formulation, it is crucial to monitor the patient's response to therapy and adjust the dosage as necessary. Tretinoin can cause side effects such as retinoic acid syndrome, which may require prompt medical attention. Additionally, the formulation's compatibility with other medications should be evaluated to prevent interactions. Pharmacists at Bayview Pharmacy are equipped to provide guidance on the proper use of this formulation, including storage, stability, and administration techniques. We also offer support in managing potential side effects and ensuring that the treatment aligns with the patient's overall care plan.
Patients and prescribers who wish to use this formulation or have any questions regarding its use, preparation, or the diseases it treats are encouraged to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is committed to providing comprehensive support and ensuring that each patient receives personalized care tailored to their specific needs.
Tretinoin, a derivative of vitamin A, is commonly used in the treatment of acne and acute promyelocytic leukemia (APL). When formulated as a 10 mg/ml gastric tube liquid, it is particularly useful for patients who are unable to take medications orally. However, it is important to consider potential drug interactions when administering tretinoin in this manner.
Firstly, tretinoin is known to interact with drugs that increase photosensitivity. Concurrent use of antibiotics such as tetracyclines or fluoroquinolones, and sulfa drugs should be approached with caution, as the combination may increase the risk of sunburn. Patients should be advised to avoid unnecessary or prolonged exposure to sunlight and to use protective clothing or sunscreen when outdoors.
Additionally, tretinoin may interact with other topical acne medications, particularly those containing benzoyl peroxide, salicylic acid, or sulfur. These combinations may lead to excessive skin irritation. If such agents are used, they should be applied at different times of the day to minimize the potential for interaction.
Medications that exhibit cytotoxic properties or those that are known to be teratogenic, such as methotrexate or aminopterin, should be used with extreme caution in patients receiving tretinoin. The combination may increase the risk of additive toxicity or teratogenic effects. It is crucial to monitor patients closely for signs of adverse reactions when these drugs are used concomitantly.
Patients receiving tretinoin should also avoid taking vitamin A supplements or other retinoids concurrently, as this may increase the risk of vitamin A toxicity, characterized by symptoms such as headache, nausea, and vomiting. Healthcare providers should assess the patient's dietary and supplement intake to ensure that there is no excessive vitamin A consumption.
It is important to note that tretinoin is metabolized by cytochrome P450 enzymes, and drugs that affect these enzymes could potentially alter the metabolism of tretinoin. For example, CYP2C8 inhibitors, such as gemfibrozil, may increase tretinoin levels, while inducers of CYP enzymes, like rifampin, could decrease its efficacy.
Lastly, antacids and other medications that alter the gastric pH may affect the absorption of tretinoin when administered via a gastric tube. It is advisable to administer tretinoin at least 2 hours before or after antacids to prevent potential interactions.
Given the complexity of drug interactions with tretinoin, it is essential for prescribers and patients to communicate openly about all medications, supplements, and over-the-counter products being used. This will allow for the identification and management of any potential interactions to ensure the safe and appropriate use of tretinoin. If you have any questions or require further information regarding drug interactions with tretinoin, please do not hesitate to reach out to us at Bayview Pharmacy.
The Tretinoin 10 mg/ml Gastric Tube Liquid is a specialized formulation designed for administration through a gastric tube. Tretinoin, the active ingredient in this formulation, is a derivative of vitamin A and is commonly used in the treatment of acute promyelocytic leukemia (APL). APL is a subtype of acute myeloid leukemia characterized by the accumulation of immature white blood cells called promyelocytes. Tretinoin works by promoting the differentiation and maturation of these cells, thereby reducing their accumulation and mitigating the symptoms of the disease.
In this liquid formulation, tretinoin is dissolved in a suitable solvent system to ensure that it maintains its stability and efficacy when administered through a gastric tube. The concentration of 10 mg/ml allows for precise dosing as per the patient's requirements. The liquid form is particularly beneficial for patients who are unable to swallow pills or capsules, such as those with dysphagia or those who are intubated or have a gastrostomy.
The mechanism of action of tretinoin in the treatment of APL involves binding to retinoic acid receptors (RARs) on the promyelocytes. This binding alters gene expression, leading to the differentiation of the promyelocytes into mature granulocytes. This process effectively reduces the promyelocyte count in the bone marrow and blood, leading to remission of the leukemia. Tretinoin is also used in dermatology for the treatment of acne and other skin conditions, but its use in a gastric tube liquid formulation is specifically for APL.
It is important for prescribers to monitor the patient's response to the treatment and adjust the dosage accordingly. The formulation must be prepared under strict aseptic conditions to prevent contamination and ensure patient safety. Additionally, the liquid should be compatible with the materials of the gastric tube to prevent any interactions that could affect the delivery of the medication.
For patients and prescribers interested in using this formulation, it is crucial to understand that the administration of tretinoin via a gastric tube requires careful consideration of the dosing schedule, potential interactions with other medications, and monitoring for side effects such as headache, fever, or skin reactions. If you have any questions or require further information about the Tretinoin 10 mg/ml Gastric Tube Liquid, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
Tretinoin 10 mg/ml Gastric Tube Liquid is a specially formulated medication that is administered through a gastric tube directly into a patient's stomach. It's designed for individuals who have difficulty swallowing or those who cannot take oral medications.
Some patients are unable to swallow tablets or capsules due to various medical conditions or procedures. This liquid formulation allows for the controlled delivery of Tretinoin to these individuals without the need for swallowing solid forms.
This medication should be stored in a cool, dry place, away from light and moisture to ensure its stability and effectiveness. It is important to follow any specific storage instructions provided by the pharmacy or manufacturer.
Dosage adjustments must be prescribed by a healthcare professional. Never alter the dose without consulting the prescribing physician, as Tretinoin dosage needs to be carefully controlled.
The liquid is administered via a gastric tube, also known as a G-tube, that is inserted directly into the stomach. This bypasses the need for swallowing and allows for the medication to be delivered efficiently to patients with swallowing difficulties.
It is crucial to consult with a healthcare provider concerning all medications currently being taken. Some drugs can interact with Tretinoin, potentially leading to adverse effects or reduced effectiveness.
Like all medications, Tretinoin can cause side effects. Commonly reported side effects include skin irritation and increased sensitivity to sunlight. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
If a dose is missed, administer it as soon as you remember, unless it is close to the time for the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule. Do not double the dose to catch up.
The use of Tretinoin in children should be determined by a pediatrician or a healthcare professional specialized in treating pediatric patients. Safety and dosage will vary based on age and medical condition.
The duration of treatment with Tretinoin varies depending on the condition being treated and the patient's response to the medication. It is important to follow the treatment plan as prescribed by the healthcare provider and not to discontinue use without their advice.
In the event of an overdose, seek immediate medical attention. Overdose symptoms can be serious, so it is important to follow the prescribed dosages carefully and keep the medication out of reach of children to prevent accidental ingestion.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
